DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Regadenoson
Regadenoson
AHFS Pharmacologic-Therapeutic Classification System
Health Plan Insights
Insight ISSUE 1
© Ferrata Storti Foundation
What Should I Know About My Cardiac Nuclear Stress Test with Lexiscan® (Regadenoson) Injection?
Rxoutlook® 1St Quarter 2019
EANM Procedural Guidelines for Radionuclide Myocardial Perfusion Imaging with SPECT and SPECT/CT
Regadenoson and Adenosine Are Equivalent
CPT / HCPCS Code Drug Description Approximate Cost Share
OUH Formulary Approved for Use in Breast Surgery
Bureau of Prisons Health Services 2018 Summer National Formulary (Part 2)
Development of MRI Methods to Assess Coronary Microvascular Function in Mice
CLINICAL POLICY Regadenoson Pharmacologic Stress Test
PRAC Minutes of the Meeting on 03-06 November 2015
Stembook 2018.Pdf
(CHMP) Agenda for the Meeting on 17-20 May 2021 Chair: Harald Enzmann – Vice-Chair: Bruno Sepodes
PRAC Agenda 25-28 November 2019
Hyperemia and Standardization
Top View
Reversible Blood-Brain Barrier Opening Utilizing the Membrane Active Peptide Melittin in Vitro and in Vivo
(12) Patent Application Publication (10) Pub. No.: US 2013/0224110 A1 Bynoe (43) Pub
Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in Vivo by Decreasing of Fibrinogen Density in Thrombus
Advances in Pharmacologic Stress Agents: Focus on Regadenoson
Administration of Medicinal Products By
2019 Table of Drugs
DEUTSCHE GESELLSCHAFT FÜR NUKLEARMEDIZIN E.V. DGN-Handlungsempfehlung (S1-Leitlinie) Myokard-Perfusions-SPECT Stand: 2/2017 –
Brand Generic Guide
The Effect of an Adenosine A2A Agonist on Intra-Tumoral
Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
Aminophylline Shortage and Current Recommendations for Reversal of Vasodilator Stress: an ASNC Information Statement Endorsed By
Atc Index 2010
The Academic News
ORIGINAL ARTICLE Safety and Tolerability of Intravenous
Lexiscan Patient Guide
YOUR GUIDE to CONTINUING Heart and Vascular Care at Asante Rogue Regional Medical Center Welcome | 1
Amplitude Integrated Electroencephalogram Study of the Effect of Caffeine Citrate on Brain Development in Low Weight Infants with Apnea
Journal of Nuclear Cardiology
Stress Protocols and Tracers
Pharmaabkommen A1 E
Nuclear Cardiology
Pharmacologic Stress Test—Regadenoson
PREVALENCE of NON-CYTOCHROME P450-MEDIATED METABOLISM in FDA APPROVED ORAL and INTRAVENOUS DRUGS: 2006 – 2015 Matthew A. Cern
Customs Tariff - Schedule Xxi - 1
Pharmacology, Part 4: Nuclear Cardiology
HHS Public Access Provided by Iupuischolarworks Author Manuscript
Lexiscan.Pdf
A Phase II, Open Label Prospective Single Center Drug Study Evaluating the Safety and Efficacy of (+)-Epicatechin in Subjects with Friedreich’S Ataxi
Purinergic Signalling and Immune Cells
Potent and Selective Ecto-5′-Nucleotidase Inhibitors
2021 Standard Charges N/ a = Not Applicable Revised 03/15/2021
A2B-Adenosin-Rezeptor-Homo- Und Heterodimere
Purinergic Regulation of Endothelial Barrier Function
Current FDA-Related Drug Information Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
HEMICHANNELS; from the MOLECULE to the FUNCTION Topic Editors Mauricio A
Paragraph IV Patent Certifications (PPIV)
"Rapiscan, INN-Regadenoson"
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
International Nonproprietary Names
RAPISCAN® (Regadenoson)
Emerging Disease-Modifying Therapies for Sickle Cell Disease
Pharmacologic and Exercise Stress Tests
Focusing on Adenosine Receptors As a Potential Targeted Therapy in Human Diseases
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Getting a Lexiscan Stress Test? Skip the Caffeine
Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y12 Antagonists in a Camp- and Calcium-Dependent Manner
Pharmacologic Stress Test: Regadenoson